Christina Ackermann Bausch Health Companies Inc. (BHC) insider trading activity

Christina Ackermann is EVP AND GENERAL COUNSEL of Bausch Health Companies Inc.. Currently has a direct ownership of 162,240 shares of BHC, which is worth approximately $1.29 Million. The most recent transaction as insider was on Mar 10, 2022, when has been sold 839 shares (Common Shares, no par value) at a price of $22.56 per share, resulting in proceeds of $18,928. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K

0% 3M change

0% 12M change

Total Value Held $1.29 Million

CHRISTINA ACKERMANN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2022	SELL Payment of exercise price or tax liability	$18,928 $22.56 p/Share	839 Reduced 0.51%	162,240 Common Shares, no par ...
Mar 03 2022	SELL Payment of exercise price or tax liability	$163,523 $23.61 p/Share	6,926 Reduced 4.07%	163,079 Common Shares, no par ...
Feb 27 2022	SELL Payment of exercise price or tax liability	$390,282 $24.35 p/Share	16,028 Reduced 8.62%	170,005 Common Shares, no par ...
Feb 27 2022	BUY Exercise of conversion of derivative security	-	24,292 Added 11.55%	186,033 Common Shares, no par ...
Aug 27 2021	SELL Payment of exercise price or tax liability	$145,242 $28.95 p/Share	5,017 Reduced 3.01%	161,741 Common Shares, no par ...
Jun 02 2021	SELL Open market or private sale	$3,857,732 $31.83 p/Share	121,198 Reduced 42.09%	166,758 Common Shares, no par ...
Jun 02 2021	BUY Exercise of conversion of derivative security	$1,799,790 $14.85 p/Share	121,198 Added 29.62%	287,956 Common Shares, no par ...
Mar 11 2021	SELL Payment of exercise price or tax liability	$26,125 $32.82 p/Share	796 Reduced 0.48%	166,758 Common Shares, no par ...
Mar 10 2021	SELL Payment of exercise price or tax liability	$724,021 $32.97 p/Share	21,960 Reduced 11.59%	167,554 Common Shares, no par ...
Mar 08 2021	BUY Grant, award, or other acquisition	-	25,980 Added 12.06%	189,514 Common Shares, no par ...
Mar 08 2021	BUY Exercise of conversion of derivative security	-	8,455 Added 4.92%	163,534 Common Shares, no par ...
Mar 03 2021	BUY Grant, award, or other acquisition	-	36,250 Added 18.95%	155,079 Common Shares, no par ...
Mar 01 2021	SELL Payment of exercise price or tax liability	$168,631 $31.42 p/Share	5,367 Reduced 4.32%	118,829 Common Shares, no par ...

Also insider at

VRNA

Verona Pharma plc Healthcare

Director

GRAY

GRAYBUG VISION, INC. Healthcare

Director

BLCO

Bausch & Lomb Corp Healthcare

Officer